Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Thrombectomy Devices Market Size, Share, Trends, and Forecast, 2026-2036 | Market to Reach USD 5.37 Billion as Aspiration Adoption and Asia-Pacific Expansion Drive 7.8% CAGR

globenewswire.com
MDT Medtronic plc is listed as a key company in the thrombectomy devices market, which is projected to grow significantly. The article does not provide specific sentiment towards Medtronic's performance but includes it in the competitive landscape. SYK Stryker Corporation is identified as a key player in the growing thrombectomy devices market. The article mentions its participation in the competitive landscape but offers no specific performance indicators or sentiment. PEN Penumbra, Inc. is listed as a key company in the thrombectomy devices market, which is expected to experience substantial growth. The article includes it in the competitive analysis without specific sentiment. BSX Boston Scientific Corporation is mentioned as a key competitor in the thrombectomy devices market, which is poised for significant expansion. The article does not provide specific sentiment for the company. JNJ Johnson & Johnson (Cerenovus) is listed as a key company in the thrombectomy devices market, which is projected to grow. The article includes it in the competitive landscape but does not offer specific sentiment. ABT Abbott Laboratories is identified as a key player in the thrombectomy devices market, which is expected to grow. The article mentions its role in the competitive landscape but provides no specific sentiment. BDX Becton, Dickinson and Company is mentioned as a participant in the thrombectomy devices market, which is expected to grow. The article includes it in the competitive landscape but provides no specific sentiment. TLF Teleflex Incorporated is listed as a key company in the thrombectomy devices market, which is projected to grow. The article includes it in the competitive landscape but does not offer specific sentiment. ANGO AngioDynamics, Inc. is mentioned as a participant in the thrombectomy devices market, which is expected to grow. The article includes it in the competitive landscape but provides no specific sentiment.

Global Thrombectomy Devices Market Size, Share, Trends, and Forecast, 2026-2036 | Market to Reach USD 5.37 Billion as Aspiration Adoption and Asia-Pacific Expansion Drive 7.8% CAGR Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Thrombectomy Devices Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.

The global thrombectomy devices market is estimated at USD 2.43 billion in 2026 and is projected to reach USD 5.37 billion by 2036, expanding at a CAGR of 7.8% during the forecast period. Growth is being supported by rising demand for mechanical thrombectomy in acute ischemic stroke, pulmonary embolism, deep vein thrombosis, and other neurovascular, peripheral vascular, and cardiovascular applications.

The report evaluates market trends, technological advancements, clinical developments, competitive strategies, and long-term growth opportunities across the thrombectomy devices value chain. It covers stent retrievers, aspiration catheters, and hybrid technologies, alongside their adoption by hospitals, comprehensive stroke centers, and other healthcare providers.

Market Growth Drivers and Opportunities

Strong clinical evidence and favorable treatment guidelines from leading cardiovascular and stroke associations continue to accelerate the adoption of mechanical thrombectomy. The expansion of treatment windows through advanced imaging has increased the number of eligible patients, while the rising prevalence of atrial fibrillation, obesity, hypertension, stroke, and thrombotic conditions is contributing to higher procedure volumes worldwide.

Growth is also being driven by the continued development of thrombectomy-capable stroke centers and broader access to endovascular therapy. Emerging opportunities include robotic-assisted thrombectomy, treatment of distal vessel occlusions, and devices featuring integrated sensors for real-time procedural feedback. The increasing use of mechanical thrombectomy for pulmonary embolism and deep vein thrombosis is expected to create additional demand as healthcare providers seek alternatives to systemic thrombolytic therapy.

Market expansion may be constrained by shortages of trained neurointerventionalists and specialized stroke teams, particularly in rural and underserved locations. High device and hospitalization costs, limited reimbursement in some markets, and the need to transfer patients rapidly to appropriately equipped facilities also remain significant adoption barriers.

Segment Insights

The report analyzes the thrombectomy devices market by product, technology, application, end user, and geography. The neurovascular segment accounts for the largest market share and is projected to record strong growth as additional stroke centers become operational and access to mechanical thrombectomy expands. Peripheral vascular applications are also advancing, supported by increased use in pulmonary embolism and deep vein thrombosis procedures.

Stent retrievers remain the leading technology segment due to extensive clinical validation and established use among neurointerventional specialists. Aspiration technology is expected to achieve the fastest growth, supported by procedural efficiency and advances in flexible, large-bore catheter design. Hybrid approaches that combine stent retrieval and aspiration are also contributing to device innovation and treatment optimization.

Regional Market Outlook

North America is expected to represent approximately 40% of global thrombectomy devices market revenue in 2026. Its leadership is supported by an established network of comprehensive stroke centers, favorable reimbursement, advanced catheterization infrastructure, and high awareness of stroke symptoms. Europe is anticipated to maintain steady growth through established stroke care systems and wider access to endovascular procedures.

Asia-Pacific is projected to register the fastest growth through 2036. Key factors include a substantial stroke burden, healthcare infrastructure investment, and the expansion of stroke centers in Tier 2 and Tier 3 cities. China represents a particularly important market because of its large patient population and increasing investment in advanced stroke care. Latin America and the Middle East & Africa are expected to provide emerging opportunities as healthcare infrastructure, specialist capacity, and stroke referral networks improve.

Competitive Landscape

The competitive assessment examines device portfolios, clinical trial pipelines, partnerships, acquisitions, geographic expansion, and recent business developments. Companies are competing on trackability, clot integration, revascularization speed, procedural performance, and the ability to address a broader range of vascular conditions.

Large-scale clinical trials are playing an important role in expanding device indications, while strategic acquisitions are enabling established manufacturers to add differentiated technologies to their portfolios. Key companies profiled include Medtronic plc, Stryker Corporation, Penumbra, Inc., Terumo Corporation (MicroVention), Boston Scientific Corporation, Johnson & Johnson (Cerenovus), Abbott Laboratories, Inari Medical, MicroPort, and Rapid Medical.

Strategic Value of the Report

The report provides actionable intelligence for medical device manufacturers, hospitals, comprehensive stroke centers, investors, consultants, and other stakeholders seeking to evaluate opportunities in the global thrombectomy devices market.

Key Topics Covered:

1. Market Definition & Scope

1.1. Market Definition

1.2. Market Ecosystem

1.3. Currency Considered

1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach

2.2. Process of Data Collection and Validation

2.2.1. Secondary Research

2.2.2. Primary Research/Interviews with Key Opinion Leaders

2.3. Market Sizing and Forecast

2.3.1. Market Size Estimation Approach

2.3.1.1. Bottom-Up Approach

2.3.1.2. Top-Down Approach

2.3.2. Growth Forecast Approach

2.3.3. Assumptions for the Study

3. Executive Summary

3.1. Overview

3.2. Segmental Analysis

3.2.1. Market Analysis, by Product

3.2.2. Market Analysis, by Technology

3.2.3. Market Analysis, by Application

3.2.4. Market Analysis, by End User

3.2.5. Market Analysis, by Geography

3.3. Competitive Analysis

4. Market Insights

4.1. Overview

4.2. Factors Affecting Market Growth

4.2.1. Drivers

4.2.1.1. Strong Clinical Evidence and Favorable AHA/ASA Guidelines

4.2.1.2. Expansion of Treatment Window for Ischemic Stroke up to 24 Hours

4.2.1.3. Rising Global Prevalence of VTE and Cardiovascular Diseases

4.2.2. Restraints

4.2.2.1. Shortage of Trained Neurointerventionalists and Specialized Teams

4.2.2.2. High Cost of Devices and Specialized Hospital Infrastructure

4.2.3. Opportunities

4.2.3.1. Development of Robotic-Assisted and Remote Thrombectomy Systems

4.2.3.2. Expansion into Distal Vessel Occlusions and Smaller Branch Strokes

4.2.4. Challenges

4.2.4.1. Logistical Delays in Transporting Patients to Specialized Stroke Centers

4.2.4.2. Risk of Procedure-Related Complications and Vessel Trauma

4.2.5. Trends

4.2.5.1. Rapid Adoption of Aspiration and Hybrid Retrieval Techniques

4.2.5.2. Establishment and Certification of Thrombectomy-Capable Stroke Centers

4.3. Porter's Five Forces Analysis

4.4. Regulatory Landscape

4.5. Value Chain Analysis

5. Global Thrombectomy Devices Market, by Product

5.1. Overview

5.2. Aspiration Thrombectomy Devices

5.3. Mechanical Thrombectomy Devices (Stent Retrievers)

5.4. Ultrasound-Assisted Thrombectomy Devices

5.5. Hydrodynamic Thrombectomy Devices

6. Global Thrombectomy Devices Market, by Technology

6.1. Overview

6.2. Stent Retriever Technology

6.3. Aspiration Technology

6.4. Hybrid Technology

7. Global Thrombectomy Devices Market, by Application

7.1. Overview

7.2. Neurovascular (Ischemic Stroke)

7.3. Peripheral Vascular (DVT, PE)

7.4. Cardiovascular (Coronary Thrombectomy)

8. Global Thrombectomy Devices Market, by End User

8.1. Overview

8.2. Hospitals & Specialty Centers (Stroke Centers)

8.3. Ambulatory Surgical Centers (ASCs)

8.4. Academic & Research Institutes

9. Global Thrombectomy Devices Market, by Geography

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. U.K.

9.3.3. France

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. Japan

9.4.3. India

9.4.4. Australia

9.4.5. Rest of Asia-Pacific

9.5. Latin America

9.5.1. Brazil

9.5.2. Mexico

9.5.3. Rest of Latin America

9.6. Middle East & Africa

10. Competitive Landscape

10.1. Overview

10.2. Key Growth Strategies

10.3. Competitive Dashboard

10.4. Vendor Market Positioning

10.5. Market Share Analysis, 2025

11. Company Profiles

11.1. Medtronic plc

11.2. Stryker Corporation

11.3. Penumbra, Inc.

11.4. Terumo Corporation (MicroVention, Inc.)

11.5. Boston Scientific Corporation

11.6. Johnson & Johnson (Cerenovus)

11.7. Becton, Dickinson and Company

11.8. Abbott Laboratories

11.9. Inari Medical, Inc.

11.10. Teleflex Incorporated

11.11. AngioDynamics, Inc.

11.12. MicroPort Scientific Corporation

11.13. Merit Medical Systems, Inc.

11.14. phenox GmbH (Wallaby Medical)

11.15. Acandis GmbH

11.16. Rapid Medical Ltd.

12. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/t72c61

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.